Breaking News

R-Pharm Buys Xcellerex FlexFactory Line

R-Pharm has purchased a 2,000L FlexFactory bioproduction line from Xcellerex for its new biologics manufacturing facility in Yaroslavl, Russia.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

R-Pharm has purchased a 2,000L FlexFactory bioproduction line from Xcellerex for its new biologics manufacturing facility in Yaroslavl, Russia. The facility represents R-Pharm’s entry into large scale manufacturing of biologics in Russia. The company expects to begin production in 2012. Xcellerex will also provide bioprocess services and training to help ensure rapid and efficient transfer of technology and expertise to support cGMP operations. “Biologics are revolutionizing the treatment of ma...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters